
Valeant offers Salix Pharmaceuticals $10.96 billion in cash and uninsured Americans go down by a third (Morning Read)
Valeant Pharmaceuticals International Inc. increased its takeover offer for Salix Pharmaceuticals Inc. to $10.96 billion in cash, eliminating Endo International Plc. as a contender as a contender, which was the only other bidder for the maker of gastrointestinal drugs.